The Clear Cell Odontogenic Carcinoma: Case Report of a Rare Jaw Malignancy.

Vasco Starke, Markus Merkl, Lukas Grössing, Mauro Pau, Wolfgang Zemann

Abstract readCase Reports

In one paragraph

Article in Journal of maxillofacial and oral surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Salivary Hyalinizing Clear Cell Carcinoma and Odontogenic Clear Cell Carcinoma: A Case Series and a Scoping Review Comparing Clinicopathological Presentations.Diagnostics (Basel, Switzerland) · 2026
Review

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Vasco StarkeDepartment of Oral and Maxillofacial Surgery, Medical University Graz, Auenbruggerplatz 5, 8036 Graz, Austria.

Markus MerklDepartment of Oral and Maxillofacial Surgery, Medical University Graz, Auenbruggerplatz 5, 8036 Graz, Austria.

Lukas GrössingDepartment of Oral and Maxillofacial Surgery, Medical University Graz, Auenbruggerplatz 5, 8036 Graz, Austria.

Mauro PauDepartment of Oral and Maxillofacial Surgery, Medical University Graz, Auenbruggerplatz 5, 8036 Graz, Austria.

Wolfgang ZemannDepartment of Oral and Maxillofacial Surgery, Medical University Graz, Auenbruggerplatz 5, 8036 Graz, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clear cell odontogenic carcinoma is a very rare malignant tumor of the jaw. Diagnosis and treatment may be challenging as the tumor grows locally aggressive and infiltrative with possible metastatic spread, while the clinical presentation varies, and the definitive diagnosis can only be confirmed by immunohistopathology. The case of a 25-year-old male patient with clear cell odontogenic carcinoma of the mandible is presented. Therapeutic treatment included primary surgical resection with bilateral removal of cervical lymph nodes followed by a two-stage reconstruction approach. Continuous follow-up over 7.5 years showed no signs of tumor recurrence.

Indexed as

Clear cell ameloblastomaMalignant odontogenic tumorOdontogenic clear cell carcinoma—CCOCTumor reconstruction

Identifiers

PMID41306197

DOI10.1007/s12663-025-02590-5

PMCPMC12644347

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.